Literature DB >> 17891499

Contrast-enhanced endoscopic ultrasound in discrimination between benign and malignant mediastinal and abdominal lymph nodes.

Michael Hocke1, Markus Menges, Theodor Topalidis, Christoph F Dietrich, Andreas Stallmach.   

Abstract

BACKGROUND: Enlarged lymph nodes in the mediastinum reflect neoplastic, infectious or other diseases. The classification of these nodes is crucial in the management of the patient. Currently, only invasive measures obtaining tissue samples reach satisfying specificity. Contrast-enhanced endoscopic ultrasound (EUS) may offer a non-invasive alternative.
MATERIALS AND METHODS: A total of 122 patients (age: 63 +/- 15 years, 92 males, 30 females) with enlarged mediastinal and/or paraaortic lymph nodes diagnosed by CT scan were included in the study. EUS-guided fine needle aspiration was performed and cytologic specimens were diagnosed as representing a malignant or benign process in case of Papanicolau IV and V, or Papanicolau I and II, respectively.
RESULTS: Based on cytology results, the investigated lymph nodes were classified as neoplastic (n = 48) or non-neoplastic lymph nodes. Using the B-mode criteria the preliminary diagnosis was confirmed in 64 out of 74 benign lymph nodes (specificity 86%). Regarding malignant lymph nodes 33 of 48 were confirmed (sensitivity 68%). Using the advanced contrast-enhanced EUS criteria the diagnosis was confirmed in 68 of 74 benign lymph nodes (specificity 91%). However, in case of malignant lymph nodes the number of correct diagnoses dropped to 29 of 48 lymph nodes (sensitivity 60%). The contrast-enhanced EUS criteria to identify benign lymph nodes and node enlargement in malignant lymphoma do not differ. If those ten patients with malignant lymphoma are excluded, the sensitivity of the contrast enhanced EUS for malignant lymph nodes rises to 73%.
CONCLUSION: Contrast-enhanced EUS improves the specificity in diagnosing benign lymph nodes as compared to B-mode EUS. It does not improve the correct identification of malignant lymph nodes and cannot replace EUS-guided fine-needle aspiration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891499     DOI: 10.1007/s00432-007-0309-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

1.  Evaluation of mediastinal lymphadenopathy with endoscopic US-guided fine-needle aspiration biopsy.

Authors:  M J Wiersema; E Vazquez-Sequeiros; L M Wiersema
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma.

Authors:  Kazunori Nakase; Kouji Yamamoto; Atsunori Hiasa; Isao Tawara; Motoko Yamaguchi; Hiroshi Shiku
Journal:  Cancer Detect Prev       Date:  2006-05-02

3.  Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis.

Authors:  Julia Kim LeBlanc; Donato Ciaccia; Mohammed T Al-Assi; Kevin McGrath; Tom Imperiale; Liang-Che Tao; Steve Vallery; John DeWitt; Stuart Sherman; Edith Collins
Journal:  Gastrointest Endosc       Date:  2004-04       Impact factor: 9.427

4.  Sonographic appearances of cervical lymph nodes: variations by age and sex.

Authors:  Michael Ying; Anil Ahuja; Fiona Brook
Journal:  J Clin Ultrasound       Date:  2002-01       Impact factor: 0.910

5.  Contrast-enhanced endoscopic ultrasonography in pancreatic diseases: a preliminary study.

Authors:  Y Hirooka; H Goto; A Ito; S Hayakawa; Y Watanabe; Y Ishiguro; S Kojima; T Hayakawa; Y Naitoh
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

6.  Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma.

Authors:  D Becker; D Strobel; T Bernatik; E G Hahn
Journal:  Gastrointest Endosc       Date:  2001-06       Impact factor: 9.427

7.  Differentiation of lymphadenopathy in different forms of carcinoma with Doppler sonography.

Authors:  S S Ho; A T Ahuja; J Kew; C Metreweli
Journal:  Clin Radiol       Date:  2000-08       Impact factor: 2.350

8.  Color Doppler sonography in the evaluation of superficial lymphomatous lymph nodes.

Authors:  Francesco Giovagnorio; Michele Galluzzo; Chiara Andreoli; Cicco Maria Luisa De; Vincenzo David
Journal:  J Ultrasound Med       Date:  2002-04       Impact factor: 2.153

9.  Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist: high accuracy for the diagnosis of mediastinal lymphadenopathy.

Authors:  Kurt G Tournoy; Marleen M Praet; Georges Van Maele; Jan P Van Meerbeeck
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

10.  Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer.

Authors:  Michael Hocke; Ewald Schulze; Peter Gottschalk; Theodor Topalidis; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

View more
  22 in total

1.  Contrast enhanced endoscopic ultrasound: More than just a fancy Doppler.

Authors:  Rachid M Mohamed; Brian M Yan
Journal:  World J Gastrointest Endosc       Date:  2010-07-16

Review 2.  Contrast-enhanced endoscopic ultrasonography.

Authors:  Nischita K Reddy; Ana Maria Ioncică; Adrian Săftoiu; Peter Vilmann; Manoop S Bhutani
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

Review 3.  Ultrasound techniques in the evaluation of the mediastinum, part 2: mediastinal lymph node anatomy and diagnostic reach of ultrasound techniques, clinical work up of neoplastic and inflammatory mediastinal lymphadenopathy using ultrasound techniques and how to learn mediastinal endosonography.

Authors:  Christian Jenssen; Jouke Tabe Annema; Paul Clementsen; Xin-Wu Cui; Mathias Maximilian Borst; Christoph Frank Dietrich
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 4.  New ultrasound techniques for lymph node evaluation.

Authors:  Xin-Wu Cui; Christian Jenssen; Adrian Saftoiu; Andre Ignee; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

5.  Endoscopic ultrasonography: an advancing option with duality in both diagnosis and treatment of gastrointestinal oncology.

Authors:  Fenglin Chen
Journal:  Chin J Cancer Res       Date:  2014-12       Impact factor: 5.087

6.  Transabdominal Ultrasonography for Preoperative Diagnosis of Lymph Node Metastasis in Colon Cancer: A Retrospective Cohort Study.

Authors:  Ken Imaizumi; Shigenori Homma; Mutsumi Nishida; Takeshi Soyama; Ryosuke Shimura; Yusuke Kudo; Satomi Omotehara; Isao Yokota; Ryo Takagi; Hiroki Matsui; Yoichi Miyaoka; Nobuki Ichikawa; Tadashi Yoshida; Norihiko Takahashi; Akinobu Taketomi
Journal:  Cancer Diagn Progn       Date:  2022-03-03

Review 7.  Contrast-enhanced endoscopic ultrasonography in digestive diseases.

Authors:  Yoshiki Hirooka; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Yuya Itoh; Yosuke Nakamura; Takeshi Hiramatsu; Hiroyuki Sugimoto; Hajime Sumi; Daijiro Hayashi; Naoki Ohmiya; Ryoji Miyahara; Masanao Nakamura; Kohei Funasaka; Masatoshi Ishigami; Yoshiaki Katano; Hidemi Goto
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

8.  Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma.

Authors:  Takeshi Miyata; Masayuki Kitano; Shunsuke Omoto; Kumpei Kadosaka; Ken Kamata; Hajime Imai; Hiroki Sakamoto; Naoshi Nisida; Yogesh Harwani; Takamichi Murakami; Yoshifumi Takeyama; Yasutaka Chiba; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 9.  Contrast-enhanced ultrasonography in interventional oncology.

Authors:  Sriharsha Gummadi; John R Eisenbrey; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2018-11

10.  2D ultrasonography and contrast enhanced ultrasound for the evaluation of cavitating mesenteric lymph node syndrome in a patient with refractory celiac disease and enteropathy T cell lymphoma.

Authors:  Cristina Pojoga; Lidia Ciobanu; Alexandru Florin Badea; Emil Boţan; Cosmin Caraiani; Claudia Hagiu; Grigore Băciuţ; Radu Badea
Journal:  BMC Gastroenterol       Date:  2013-02-11       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.